dr. reddy's laboratories
(DRRD:National Stock Exchange of India)
R. Rajgopalan Ph.D.
Member of the Scientific Advisory Board, Dr. Reddy's Laboratories Ltd.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 1 different industries.|
See Board Relationships
R. Rajgopalan, PhD served as President of Discovery Research and In charge of Research and Development activities of Dr. Reddy's Laboratories Ltd. since 2001. Mr. Rajgopalan served as a Member of the Management Council at Dr. Reddy's Laboratories Ltd. Mr. Rajgopalan started his career with Hoechst India Ltd. and was associated with their drug discovery program in various capacities for over two decades. He served as the Principal Research Scientist in Hoechst, where ...
8-2-337, Road No. 3Phone: 91 40 4900 2900
Hyderabad, Andhra Pradesh 500034
Fax: 91 40 4900 2999
Board Members Memberships*There is no Board Members Memberships data available.
University of Madras
University of Madras
University of Mumbai
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Kalyanasundaram Subramanian||Chief Executive Officer and Director|
Taro Pharmaceutical Industries Ltd.
|Stephen Edward Foots||Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee|
Croda International plc
|Heinz-Jurgen Bertram Ph.D.||Chairman of Executive Board, Chief Executive Officer and Labour Director|
|Pankaj R. Patel M.Pharm||Chairman, Managing Director, Chairman of Share Transfer Committee, Chairman of Committee of Directors and Member of Shareholders'/Investors' Grievance Committee|
Cadila Healthcare Limited
|Subhanu Saxena||Managing Director, Global Chief Executive Officer and Director|
|137.5M||Compensation as of Fiscal Year --.|